Are Branded and Generic Extended-Release Ropinirole Formulations Equally Efficacious? A Rater-Blinded, Switch-Over, Multicenter Study

The aim of this study was to compare the efficacy of the branded and a generic extended-release ropinirole formulation in the treatment of advanced Parkinson's disease (PD). Of 22 enrolled patients 21 completed the study. A rater blinded to treatment evaluated Unified Parkinson's Disease R...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosnyák, Edit, Herceg, Mihály, Pál, Endre, Aschermann, Zsuzsanna, Janszky, József, Késmárki, Ildikó, Komoly, Sámuel, Karádi, Kázmér, Dóczi, Tamás, Nagy, Ferenc, Kovács, Norbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160606/
https://www.ncbi.nlm.nih.gov/pubmed/25247107
http://dx.doi.org/10.1155/2014/158353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160606/
https://www.ncbi.nlm.nih.gov/pubmed/25247107
http://dx.doi.org/10.1155/2014/158353

Ejemplares similares